Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
International Psychogeriatrics|January 13, 2016
A point prevalence study of the use of psychotropic medication in an acute general hospitalScott Brunero, Anne P F Wand, Scott Lamont, et al.
Journal of Nursing Management|November 8, 2014
Collaboration amongst clinical nursing leadership teams: a mixed-methods sequential explanatory studyScott Lamont, Scott Brunero, Sarah Lyons, et al.
Journal of Clinical Nursing|April 19, 2021
Examining the utility of the Violence Prevention Climate scale: In a metropolitan Australian general hospitalScott Brunero, Scott Lamont, Sarah Dunn, et al.
Journal of Bioethical Inquiry|November 10, 2020
Mental Capacity Assessments for COVID-19 Patients: Emergency Admissions and the CARD ApproachCameron Stewart, Paul Biegler, Scott Brunero, et al.
Journal of Advanced Nursing|November 20, 2016
'Mental health day' sickness absence amongst nurses and midwives: workplace, workforce, psychosocial and health characteristicsScott Lamont, Scott Brunero, Lin Perry, et al.
Nursing Reports (Pavia, Italy)|February 26, 2026
Characterising Challenging Behaviour Following Stroke: A Retrospective Chart Review of Presentation, Management, and OutcomesScott Lamont, Catherine E Lightbody, Malabika Ghosh, et al.
Canadian Journal of Rural Medicine : the Official Journal of the Society of Rural Physicians of Canada = Journal Canadien De La Medecine Rurale : Le Journal Officiel De La Societe De Medecine Rurale Du Canada|June 29, 2019
Standardised early warning scores in rural interfacility transfers: A pilot study into their potential as a decision-making aidAndrew Stanley, Holly Buhler, Brent Hobbs, et al.
Chemical Communications (Cambridge, England)|August 22, 2013
Flexible access to conformationally-locked bicyclic morpholinesRachael Bogacki, Duncan M Gill, William J Kerr, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2013
Hydantoin based inhibitors of MMP13--discovery of AZD6605Chris De Savi, David Waterson, Andrew Pape, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritisChris De Savi, Andrew Pape, Yvonne Sawyer, et al.
Pageof 7